Fingerprint
Dive into the research topics of 'Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel
Tomasz M. Beer, Celestia S. Higano, Mansoor Saleh, Robert Dreicer, Gary Hudes, Joel Picus, Mark Rarick, Louis Fehrenbacher, Alison L. Hannah
Research output: Contribution to journal › Article › peer-review
50
Citations
(Scopus)